The Role of Insulin-Like Growth Factor 1 And Irisin in Muscle Dystrophy: Effect of Age and Comparison Among Patients

Authors

  • Zeena Firas Haider University of Baghdad , Biotechnology Department , College of Sciences
  • Shaima Razaq Ibraheem University of Baghdad , Biotechnology Department , College of Sciences https://orcid.org/0000-0002-2605-4133

DOI:

https://doi.org/10.37359/JOPE.V38(SpecialIssue)2026.2401

Keywords:

Muscle dystrophy, IGF-1, ELISA, irisin

Abstract

Background: Muscle dystrophy and sarcopenia involve progressive muscle wasting and functional decline. Insulin-like growth factor 1 (IGF-1) and irisin are key myokines regulating muscle growth and metabolism. Changes in their levels may reflect disease and aging effects. To evaluate the role of IGF-1 and irisin in muscle dystrophy. Methods: A case–control study was conducted in Baghdad hospitals (Dec 2024–Feb 2025) involving 55 patients with muscle dystrophy and 35 healthy controls. Serum IGF-1 and irisin were quantified utilizing ELISA, and data were analyzed with SPSS v26 (p ≤ 0.05). Results: Patients had significantly lower IGF-1 (75.18 ± 3.16 vs. 112.14 ± 8.75 ng/ml, p = 0.0001) and irisin (5.19 ± 0.22 vs. 9.92 ± 0.78 ng/ml, p = 0.0001) levels. Irisin declined with age, especially >70 years (p = 0.0481). No correlation was found between IGF-1 and irisin. Conclusion: This study suggests a potential role of IGF-1 and irisin in muscle dystrophy progression                                                                       

References

Baek, J. Y., Jang, I.-Y., Jung, H.-W., Park, S. J., Lee, J. Y., Choi, E., Lee, Y. S., Lee, E., & Kim, B.-J. (2022a). Serum irisin level is independent of sarcopenia and related muscle parameters in older adults. Experimental Gerontology, 162, 111744. https://doi.org/10.1016/j.exger.2022.111744

Colaianni, G., Oranger, A., Dicarlo, M., Lovero, R., Storlino, G., Pignataro, P., Fontana, A., Di Serio, F., Ingravallo, A., Caputo, G., Di Leo, A., Barone, M., & Grano, M. (2022). Irisin serum levels and skeletal muscle assessment in a cohort of Charcot-Marie-Tooth patients. Frontiers in Endocrinology, 13, 886243. https://doi.org/10.3389/fendo.2022.886243

de Alcantara Borba, D., da Silva Alves, E., Rosa, J. P. P., Facundo, L. A., Costa, C. M. A., Silva, A. C., Narciso, F. V., Silva, A., & de Mello, M. T. (2020). Can IGF-1 Serum Levels Really be Changed by Acute Physical Exercise? A Systematic Review and Meta-Analysis. Journal of physical activity & health, 17(5), 575–584. https://doi.org/10.1123/jpah.2019-0453

Erskine, R. M., & Degens, H. (2019). Muscle Growth, repair, and preservation. Nutrition and Enhanced Sports Performance, 291–308. https://doi.org/10.1016/B978-0-12-813922-6.00025-4

Feng L, Li B, Xi Y, Cai M, Tian Z. Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1/IGF-1R-PI3K/Akt pathway in mice with myocardial infarction. Am J Physiol Cell Physiol. 2021 Dec 1;322(2):C164-C176. https://doi.org/10.1152/ajpcell.00344.2021

Gustafsson, T., & Ulfhake, B. (2024). Aging Skeletal Muscles: What Are the Mechanisms of Age-Related Loss of Strength and Muscle Mass, and Can We Impede Its Development and Progression? International Journal of Molecular Sciences, 25(20), 10932. https://doi.org/10.3390/ijms252010932

Iglesias, P. (2025). Muscle in Endocrinology: From Skeletal Muscle Hormone Regulation to Myokine Secretion and Its Implications in Endocrine–Metabolic Diseases. Journal of Clinical Medicine, 14(13), 4490. https://doi.org/10.3390/jcm14134490

Jiang, J. J., Chen, S. M., Chen, J., Wu, L., Ye, J. T., & Zhang, Q. (2022). Serum IGF-1 levels are associated with sarcopenia in elderly men but not in elderly women. Aging clinical and experimental research, 34(10), 2465–2471. https://doi.org/10.1007/s40520-022-02180-2

Merawati, D., Sugiharto, Susanto, H., Taufiq, A., Pranoto, A., Amelia, D., & Rejeki, P. S. (2023). Dynamic of irisin secretion change after moderate-intensity chronic physical exercise on obese female. Journal of basic and clinical physiology and pharmacology, 34(4), 539–547. https://doi.org/10.1515/jbcpp-2023-0041

Mizera, Ł., Halupczok-Żyła, J., Kolačkov, K., Zembska, A., Grzegrzółka, J., Jędrzejuk, D., Bolanowski, M., & Daroszewski, J. (2021). Myokines in acromegaly: An altered irisin profile. Frontiers in Endocrinology, 12, 728734. https://doi.org/10.3389/fendo.2021.728734

Motsiuk, V. M., & Pentiuk , N. O. (2023). Serum myostatin and irisin as predictive biomarkers of sarcopenia, malnutrition and mortality in patients with decompensated liver cirrhosis. Reports of Morphology, 29(2), 18–25. https://doi.org/10.31393/morphology-journal-2023-29(2)-03

Rahmani, J., Montesanto, A., Giovannucci, E., Zand, H., Barati, M., Kopchick, J. J., Mirisola, M. G., Lagani, V., Bawadi, H., Vardavas, R., Laviano, A., Christensen, K., Passarino, G., & Longo, V. D. (2022). Association between IGF-1 levels ranges and all-cause mortality: A meta-analysis. Aging cell, 21(2), e13540. https://doi.org/10.1111/acel.13540

Robinson-Agramonte, M.d.l.A., Michalski, B., Vidal-Martinez, B. et al. BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism. Sci Rep 12, 13768 (2022). https://doi.org/10.1038/s41598-022-17503-6

Sakai, H., Asami, M., Naito, H., Kitora, S., Suzuki, Y., Miyauchi, Y., Tachinooka, R., Yoshida, S., Kon, R., Ikarashi, N., Chiba, Y., & Kamei, J. (2021). Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice. Journal of cachexia, sarcopenia and muscle, 12(6), 1570–1581. https://doi.org/10.1002/jcsm.12760

Sanesi, L., Dicarlo, M., Pignataro, P., Zerlotin, R., Pugliese, F., Columbu, C., Carnevale, V., Tunnera, S., Scillitani, A., Grano, M., Colaianni, G., & Colucci, S. (2023). Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle. International Journal of Molecular Sciences, 24(4), 4129. https://doi.org/10.3390/ijms24044129

Sarto F, Monti E, Paganini M, et al. Age-related alterations in human motor units properties and in muscle innervation profile. Physiol. ;38(S1):5729129. doi: 10.1152/physiol.2023.38.S1.5729129.

Sendur, S. N., Baykal, G., Firlatan, B., Aydin, B., Lay, I., Dagdelen, S., Alikasifoglu, M., & Erbas, T. (2022). Reduced irisin levels in patients with acromegaly. Hormone molecular biology and clinical investigation, 43(3), 251–261. https://doi.org/10.1515/hmbci-2022-0009

Sheptulina, A. F., Mamutova, E. M., Elkina, A. Y., Timofeev, Y. S., Metelskaya, V. A., Kiselev, A. R., & Drapkina, O. M. (2024). Serum Irisin, Myostatin, and Myonectin Correlate with Metabolic Health Markers, Liver Disease Progression, and Blood Pressure in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Hypertension. Metabolites, 14(11), 584. https://doi.org/10.3390/metabo14110584

Zhao, C., Wu, Y., Zhu, S., Liu, H., & Xu, S. (2024). Irisin Protects Musculoskeletal Homeostasis via a Mitochondrial Quality Control Mechanism. International Journal of Molecular Sciences, 25(18), 10116. https://doi.org/10.3390/ijms251810116

Downloads

Published

2026-10-28

How to Cite

1.
Haider ZF, Ibraheem SR. The Role of Insulin-Like Growth Factor 1 And Irisin in Muscle Dystrophy: Effect of Age and Comparison Among Patients. jope [Internet]. 2026 Oct. 28 [cited 2026 Oct. 28];38(Special Issue):3116-22. Available from: https://jcope.uobaghdad.edu.iq/index.php/jcope/article/view/2401

Similar Articles

1-10 of 405

You may also start an advanced similarity search for this article.